Free Trial
OTCMKTS:CHSYF

China Medical System (CHSYF) Stock Price, News & Analysis

$0.93
0.00 (-0.06%)
(As of 05/1/2024)
Today's Range
$0.93
$0.93
50-Day Range
$0.93
$0.93
52-Week Range
$0.93
$0.93
Volume
100 shs
Average Volume
733 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CHSYF stock logo

About China Medical System Stock (OTCMKTS:CHSYF)

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. It also offers DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company provides Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.

CHSYF Stock Price History

CHSYF Stock News Headlines

The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
RemeGen Co. Ltd. A
The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
S.GREATER CHINA AC PR DL (Q5P4.Z)
See More Headlines
Receive CHSYF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Medical System and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:CHSYF
CIK
N/A
Fax
N/A
Employees
4,400
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Kong Lam (Age 59)
    Founder, Chairman, CEO & President
    Comp: $762.79k
  • Ms. Yanling Chen (Age 54)
    CFO, VP & Executive Director
    Comp: $481.08k
  • Mr. Hongbing Chen (Age 57)
    COO, VP, Director of Sales & Marketing and Executive Director
    Comp: $664.28k
  • Ms. Sanyan Wu (Age 41)
    Director of Legal Department & Company Secretary
  • Dr. Huaizheng Peng M.D. (Age 62)
    Ph.D., Chief Business Officer
  • Mr. Fei Jiang
    Chief Investment Officer of Greater China
  • Mr. James Patrick Stearns (Age 45)
    Chief Investment Officer of Europe & America

CHSYF Stock Analysis - Frequently Asked Questions

How have CHSYF shares performed this year?

China Medical System's stock was trading at $1.5180 at the beginning of the year. Since then, CHSYF stock has decreased by 38.7% and is now trading at $0.9307.
View the best growth stocks for 2024 here
.

How do I buy shares of China Medical System?

Shares of CHSYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CHSYF) was last updated on 9/9/2024 by MarketBeat.com Staff

From Our Partners